Product correctly added to cart.

discount label
D-159687
View 3D

Biosynth logo

D-159687

CAS: 1155877-97-6

Ref. 3D-FWB87797

25mg
241.00 €
50mg
377.00 €
100mg
559.00 €
250mg
1,045.00 €
500mg
1,741.00 €
Estimated delivery in United States, on Monday 13 Jan 2025

Product Information

Name:
D-159687
Description:

D-159687 is a cyclic nucleotide phosphodiesterase inhibitor that blocks the breakdown of cyclic nucleotides, resulting in increased levels of cAMP and cGMP. It has been shown to be safe and effective for the treatment of depression and has been found to have a profile similar to that of selective serotonin reuptake inhibitors (SSRIs). D-159687 is currently being tested for its potential use in treating influenza virus infections, as well as skin conditions such as psoriasis. The effects of D-159687 on mitochondrial biogenesis have been studied using mouse hippocampal cells and x-ray crystal structures. In this model, D-159687 increases mitochondrial DNA copy number by upregulating transcription factors such as nuclear respiratory factor 1 (NRF1) and nuclear respiratory factor 2 (NRF2).

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
366.84 g/mol
Formula:
C21H19ClN2O2
Purity:
Min. 98%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FWB87797 D-159687

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".